1 day Ago By Defense World Staff
Renaissance Technologies LLC trimmed its position in shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Free Report) by 4.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
The firm owned 507,163 shares of the specialty pharmaceutical company’s stock after selling 21,000 shares during the period. Renaissance Technologies LLC owned 3.61% of Cumberland Pharmaceuticals worth $1,202,000 at the end of the most recent reporting period.
Analyst Upgrades and DowngradesSeparately, StockNews.com raised Cumberland Pharmaceuticals from a “hold” rating to a “buy” rating in a report on Thursday, March 6th.View Our Latest Stock Report on Cumberland PharmaceuticalsCumberland Pharmaceuticals Trading Up 2.
1 %Shares of CPIX opened at $4.87 on Wednesday. The firm has a market cap of $68.
02 million, a P/E ratio of -6.32 and a beta of -0.24.
The company has a debt-to-equity ratio of 0.41, a current ratio of 1.13 and a quick ratio of 0.
99. Cumberland Pharmaceuticals Inc. has a 1 year low of $1.
04 and a 1 year high of $7.25. The company has a 50 day simple moving average of $4.
81 and a two-hundred day simple moving average of $3.12. Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) last posted its earnings results on Tuesday, March 4th.
The specialty pharmaceutical company reported ($0.03) earnings per share for the quarter. Cumberland Pharmaceuticals had a negative net margin of 29.
54% and a negative return on equity of 9.50%. The company had revenue of $10.
44 million for the quarter. Cumberland Pharmaceuticals Company Profile (Free Report)Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
See AlsoFive stocks we like better than Cumberland PharmaceuticalsWhat Does Downgrade Mean in Investing?Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over YetWhat is a buyback in stocks? A comprehensive guide for investorsCoca-Cola Company Stock Can Bubble to New Highs This YearGrowth Stocks: What They Are, What They Are Not3 Stocks Lifting 2025 Guidance Despite Market JittersWant to see what other hedge funds are holding CPIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Free Report).
.
